Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Veterans with PTSD and Alcohol Use Disorder
NCT02469259Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Feb 2016
- Primary completion
- Feb 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin in post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD), sponsored by University of California, San Francisco. Primary endpoints: Reading the Eyes in the Mind at 60 months and Approach Avoidance Task at 65 months. Started Feb 2016; status: completed.
02
Drugs
oxytocin
03
Conditions
post-traumatic stress disorder (PTSD)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02469259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02469259.